{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:22:04Z","timestamp":1767842524751,"version":"3.49.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,11,10]]},"DOI":"10.18632\/oncotarget.27803","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:42:07Z","timestamp":1605022927000},"page":"4104-4114","source":"Crossref","is-referenced-by-count":8,"title":["Association between vitamin D and ovarian cancer development in <i>BRCA1<\/i> mutation carriers"],"prefix":"10.18632","volume":"11","author":[{"given":"Tanja","family":"Pejovic","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Joshi","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Campbell","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Thisted","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Present address: College of Health and Human Services, Northern Arizona University, Flagstaff, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhua","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, Portland, Oregon, USA"},{"name":"Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"6","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"7","author":"Jemal","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hoc.2018.07.003","article-title":"Early Detection of Ovarian Cancer","volume":"3","author":"Bast","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"4","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"10","author":"Garcia","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5","doi-asserted-by":"publisher","first-page":"341723","DOI":"10.1155\/2015\/341723","article-title":"Hereditary ovarian cancer: not only BRCA 1 and 2 genes","volume":"201","author":"Cortesi","year":"2015","journal-title":"Biomed Res Int"},{"key":"6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrm2831","article-title":"BRCA1 and its toolbox for the maintenance of genome integrity","volume":"1","author":"Chen","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"2","author":"Engel","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","article-title":"BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark","volume":"1","author":"Ramus","year":"2008","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"31","author":"Rookus","year":"2017","journal-title":"JAMA"},{"key":"10","article-title":"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer","author":"Amemiya","year":"1993","journal-title":"GeneReviews((R))"},{"key":"11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"10","author":"Domchek","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"15","author":"Foulkes","year":"2018","journal-title":"Gynecol Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"1","author":"Rocca","year":"2015","journal-title":"Climacteric"},{"key":"14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"9","author":"Carmeliet","year":"2016","journal-title":"Physiol Rev"},{"key":"15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2010.06.008","article-title":"Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer","volume":"11","author":"Zola","year":"2010","journal-title":"Gynecol Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13048-016-0243-x","article-title":"Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damage","volume":"9","author":"Molinari","year":"2016","journal-title":"J Ovarian Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"1","author":"Neel","year":"2019","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","article-title":"Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D","volume":"5","author":"Feldman","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ygyno.2011.01.023","article-title":"Meta-analysis: Circulating vitamin D and ovarian cancer risk","volume":"12","author":"Brenner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ypmed.2013.08.026","article-title":"Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis","volume":"5","author":"Brenner","year":"2013","journal-title":"Prev Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/ije\/dyw207","article-title":"Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study","volume":"4","author":"Lu","year":"2016","journal-title":"Int J Epidemiol"},{"key":"22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13046-017-0517-1","article-title":"Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor gamma are overexpressed in BRCA1 mutated breast cancer and predict prognosis","volume":"3","author":"Ditsch","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"23","first-page":"239","article-title":"Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis","volume":"5","author":"Coombes","year":"1991","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status","volume":"1","author":"Vieth","year":"2005","journal-title":"Osteoporos Int"},{"key":"25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/SMJ.0000000000000051","article-title":"Vitamin D insufficiency\/deficiency management","volume":"10","author":"Olive","year":"2014","journal-title":"South Med J"},{"key":"26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jsbmb.2006.12.019","article-title":"Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3","volume":"10","author":"Pike","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3389\/fphys.2018.01600","article-title":"Vitamin D3 Regulates Follicular Development and Intrafollicular Vitamin D Biosynthesis and Signaling in the Primate Ovary","volume":"9","author":"Hennebold","year":"2018","journal-title":"Front Physiol"},{"key":"28","doi-asserted-by":"publisher","first-page":"25260","DOI":"10.1074\/jbc.M311052200","article-title":"p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E\/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein\/Skp2 ubiquitin ligase","volume":"27","author":"Bai","year":"2004","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3349\/ymj.2016.57.1.33","article-title":"Anti-Proliferative and Apoptotic Activities of Mullerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines","volume":"5","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"29","author":"Tung","year":"2006","journal-title":"JAMA"},{"key":"31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.maturitas.2017.03.003","article-title":"Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement","volume":"10","author":"Rees","year":"2017","journal-title":"Maturitas"},{"key":"32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study","volume":"1","author":"Zweemer","year":"2015","journal-title":"BMC Cancer"},{"key":"33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/GRF.0000000000000318","article-title":"Ovarian Cancer Prevention in High-risk Women","volume":"6","author":"Minasian","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1634\/theoncologist.2016-0444","article-title":"Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act","volume":"2","author":"Goodman","year":"2017","journal-title":"Oncologist"},{"key":"35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"37","author":"Reeves","year":"2008","journal-title":"Lancet"},{"key":"36","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian","volume":"7","author":"Friedenson","year":"2005","journal-title":"MedGenMed"},{"key":"37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00432-012-1161-y","article-title":"Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers","volume":"13","author":"Perez-Segura","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jsbmb.2013.11.004","article-title":"Fundamentals of vitamin D hormone-regulated gene expression","volume":"14","author":"Meyer","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.fertnstert.2016.08.037","article-title":"Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimullerian hormone production","volume":"10","author":"Seifer","year":"2016","journal-title":"Fertil Steril"},{"key":"40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jsbmb.2010.02.011","article-title":"Genome-wide analysis of the VDR\/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone","volume":"12","author":"Pike","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"41","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1101\/gr.107920.110","article-title":"A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution","volume":"2","author":"Giovannoni","year":"2010","journal-title":"Genome Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/ijerph16020189","article-title":"Controversies Surrounding Vitamin D: Focus on Supplementation and Cancer","volume":"1","author":"Colangelo","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"43","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41401-018-0184-6","article-title":"Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment","volume":"4","author":"Yang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"44","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1038\/onc.2016.77","article-title":"Vitamin D\/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence","volume":"3","author":"Gonzalo","year":"2016","journal-title":"Oncogene"},{"key":"45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1210\/me.2008-0075","article-title":"Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells","volume":"2","author":"Walker","year":"2009","journal-title":"Mol Endocrinol"},{"key":"46","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/sj.onc.1203888","article-title":"The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression","volume":"1","author":"Koeffler","year":"2000","journal-title":"Oncogene"},{"key":"47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"8","author":"Heaney","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/jama.2017.2115","article-title":"Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial","volume":"31","author":"McDonnell","year":"2017","journal-title":"JAMA"},{"key":"49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3945\/ajcn.111.015032","article-title":"Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women\u2019s Health Initiative (WHI) limited-access data set","volume":"9","author":"Reid","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"50","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1096\/fj.201902217R","article-title":"Rapid actions of anti-Mullerian hormone in regulating synaptic transmission and long-term synaptic plasticity in the hippocampus","volume":"3","author":"Xu","year":"2020","journal-title":"FASEB J"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:43:22Z","timestamp":1605023002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":50,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2020,11,10]]}},"alternative-id":["27803"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27803","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}